Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study

Area of Science:

• Reproductive biology
• Maternal-fetal medicine
• Endocrinology

Background:

• Preeclampsia is a serious pregnancy complication.
• Angiogenic factors play a role in preeclampsia pathophysiology.
• Human chorionic gonadotropin (hCG) is a key pregnancy hormone.

Purpose of the Study:

• To investigate the association between maternal serum concentrations of human chorionic gonadotropin (hCG) and preeclampsia risk.
• To examine the combined role of hCG, soluble fms-like tyrosine kinase 1, and placental growth factor (PlGF) in preeclampsia development.

Main Methods:

• Nested case-control study within a population cohort of pregnant women.
• Measurement of hCG, soluble fms-like tyrosine kinase 1, and PlGF in maternal serum across trimesters.
• Analysis of odds ratios for preterm and term preeclampsia.

Main Results:

• First-trimester high hCG associated with reduced preterm preeclampsia risk.
• Second-trimester high hCG linked to increased preterm preeclampsia risk.
• Third-trimester high hCG associated with increased term preeclampsia risk.
• Combined high hCG and low PlGF in the second trimester showed a very high risk for preterm preeclampsia.

Conclusions:

• Human chorionic gonadotropin (hCG) plays a significant role in preeclampsia pathogenesis.
• The interplay between hCG and PlGF suggests synergistic biological pathways in preeclampsia.